🇬🇧 GSK.L — GSK plc

Healthcare Mantener
← Volver

Precio actual

1.837,50 GBp

Máx. histórico

2.746,59

1546 días

Split 4:5 del 19/07/2022

Caída desde máximo

-33,10%

Rango 52 semanas

1.445,00 – 2.282,00

Variación hoy

-0,49%

Cierre anterior

1.846,50

Rango de hoy

1.825,50 – 1.849,50

Volumen hoy

3.667.724

Información
Nombre completo
GSK plc
Divisa
GBp
Mercado
LSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
66.841
PER ⓘ
15,57 (puede no estar actualizado)
Dividend yield
3,68% (puede no estar actualizado)
Precio objetivo analistas
2.168,80 GBp (puede no estar actualizado)
Primera cotización
01/07/1988
Precio actualizado
hace 6 horas
Sobre la empresa

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Dividendos repartidos Total últimos 12 meses: 68,0000 GBp · Yield: 3,70%
Fecha de pago Importe por participación
13/08/2026 17,0000 GBp
14/05/2026 17,0000 GBp
19/02/2026 18,0000 GBp
13/11/2025 16,0000 GBp
14/08/2025 16,0000 GBp
15/05/2025 16,0000 GBp
20/02/2025 16,0000 GBp
14/11/2024 15,0000 GBp
15/08/2024 15,0000 GBp
16/05/2024 15,0000 GBp
22/02/2024 16,0000 GBp
16/11/2023 14,0000 GBp
17/08/2023 14,0000 GBp
18/05/2023 14,0000 GBp
23/02/2023 13,7500 GBp
Splits Registrados en el histórico de precios
Fecha Ratio
19/07/2022 4:5
28/10/1991 2:1
24/11/1989 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/03/2016 1.408,29 1.411,81 1.402,24 1.406,78 -0,04% 0,68% 7.288.334
22/03/2016 1.390,15 1.447,15 1.375,55 1.407,28 +0,90% 5,15% 16.234.145
21/03/2016 1.393,18 1.408,29 1.382,60 1.394,69 -0,04% 1,84% 5.580.147
18/03/2016 1.410,80 1.414,46 1.389,15 1.395,19 -1,04% 1,79% 15.004.009
17/03/2016 1.429,94 1.447,57 1.394,18 1.409,80 -0,89% 3,73% 11.733.511
16/03/2016 1.424,40 1.428,43 1.404,07 1.422,39 -0,28% 1,71% 7.623.942
15/03/2016 1.422,89 1.433,97 1.414,99 1.426,42 +0,43% 1,33% 7.996.846
14/03/2016 1.413,83 1.429,94 1.407,28 1.420,37 +0,86% 1,60% 7.031.825
11/03/2016 1.410,80 1.419,28 1.402,24 1.408,29 +0,87% 1,21% 6.151.262
10/03/2016 1.421,89 1.431,96 1.396,06 1.396,20 -1,21% 2,52% 8.891.015
09/03/2016 1.407,28 1.421,89 1.404,26 1.413,32 +0,21% 1,25% 8.137.865
08/03/2016 1.379,58 1.410,30 1.379,58 1.410,30 +1,82% 2,23% 9.588.337
07/03/2016 1.377,06 1.390,15 1.372,02 1.385,12 +0,36% 1,32% 5.579.921
04/03/2016 1.383,10 1.387,64 1.373,53 1.380,08 +0,00% 1,02% 7.685.811
03/03/2016 1.401,23 1.404,76 1.375,04 1.380,08 -1,86% 2,12% 10.900.345
02/03/2016 1.414,83 1.429,94 1.396,05 1.406,27 -1,34% 2,40% 12.472.360
01/03/2016 1.412,32 1.428,94 1.402,24 1.425,41 +1,11% 1,89% 7.842.993
29/02/2016 1.417,86 1.424,40 1.398,72 1.409,80 -0,78% 1,81% 12.325.329
26/02/2016 1.433,97 1.435,99 1.412,32 1.420,88 +0,25% 1,65% 6.920.888
25/02/2016 1.387,13 1.418,36 1.385,62 1.417,35 +3,42% 2,36% 9.124.715
24/02/2016 1.393,68 1.393,68 1.364,97 1.370,51 -1,27% 2,06% 8.983.486
23/02/2016 1.391,16 1.399,72 1.384,94 1.388,14 -0,97% 1,06% 5.970.335
22/02/2016 1.407,78 1.415,84 1.402,24 1.401,74 +0,58% 0,97% 5.178.648
19/02/2016 1.389,65 1.447,57 1.383,61 1.393,68 +0,25% 4,60% 7.070.296
18/02/2016 1.400,73 1.401,23 1.377,56 1.390,15 -3,09% 1,69% 9.576.880
17/02/2016 1.431,46 1.437,50 1.423,90 1.434,48 +0,46% 0,95% 10.165.461
16/02/2016 1.428,43 1.430,45 1.411,81 1.427,93 +0,46% 1,30% 7.289.007
15/02/2016 1.406,78 1.430,20 1.398,72 1.421,38 +3,48% 2,24% 9.565.584
12/02/2016 1.367,49 1.375,04 1.352,38 1.373,53 +1,34% 1,66% 10.197.661
11/02/2016 1.362,96 1.377,56 1.347,34 1.355,40 -0,99% 2,22% 11.255.819